Cancer Therapy
New Cancer Therapy Study Findings Have Been Reported by M. Maffezzini and Colleagues
Published in Cancer Weekly, February 1st, 2011
2011 FEB 1 -- In this recent study, researchers in Genoa, Italy conducted a study "To evaluate the potential contribution of a fluorescent in situ hybridization (FISH) as prognostic indicator of the risk of recurrence or progression in patients undergoing follow-up for non-muscle-invasive bladder cancer (NMIBC). A total of 126 consecutive patients with a history of NMIBC being followed-up with urinary cytology and cystoscopy at a referral centre were studied."
"with carcinoma in situ, or tumour stage higher than pT1 were excluded. A UroVysion FISH kit was used to detect four chromosomal abnormalities, specifically, locus 9p21, Ch 3, 7, and 17. Three FISH...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2011-02-01)
More Articles from Cancer Weekly
- Genetics and Breast Cancer
Susan G. Komen for the Cure(R) Unites More Than 100 Breast Cancer Survivors, Activists in Paradise - Genetics and Colon Cancer
Study Results from Trinity College Dublin Update Understanding of Genetics and Colon Cancer - Genetics and Bladder Cancer
Study Results from Dartmouth University, Norris Cotton Cancer Center Broaden Understanding of Genetics and Bladder Cancer - Gastric Cancer
Study Findings from China Medical University Broaden Understanding of Gastric Cancer - Lung Cancer
Study Data from NanJing University, Department of Respiratory Medicine Update Knowledge of Lung Cancer - Chronic Liver Disease
Study Data from Ghent University Update Knowledge of Chronic Liver Disease - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
